The Vanderbilt Transplant Center, one of the largest organ transplant programs in the Southeast, is on pace to surpass last year’s transplant totals with 254 solid organ transplantations to date.
There are many reasons why David Shaffer, M.D., surgical director of the Kidney Transplantation Program at Vanderbilt University Medical Center, loves his job.
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
Accessibility Tools